Temozolomide in Treating Patients With Leptomeningeal Metastases From a Solid Tumor or Lymphoma

This study has been completed.

Study NCT00005812 Information provided by National Cancer Institute (NCI)

First Received: June 2, 2000 Last Updated: March 22, 2010 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Study Status:	This study has been completed.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	No date given

Publications:

Davis TH, Fadul CE, Glantz MJ, et al.: Pilot phase II trial of temozolomide for leptomeningeal metastases: preliminary report. [Abstract] Proceedings of the American Society of Clinical Oncology 22: A-460, 2003.